Dextran-based polymer tissue adhesive for medical use

• US 9,370,601 B2
• Filed: 08/21/2014
• Issued: 06/21/2016
• Est. Priority Date: 11/14/2007
• Status: Active Grant

• Current Assignee: Actamax Surgical Materials, LLC (DSM-Firmenich AG)
• Original Assignee: Actamax Surgical Materials, LLC (DSM-Firmenich AG)
• Inventors: Lu, Helen S. M.
• Primary Examiner(s): Blanchard, David J
• Assistant Examiner(s): Gotfredson, Garen
• Application Number:
  US14/465,037
• Publication Number:
  US 20150105346A1
• Time in Patent Office: 670 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A61L 24/0031 Hydrogels or hydrocolloids
• CPC Class Codes: A61L 24/08 Polysaccharides A61L24/043 takes precedence
• CPC Class Codes: A61P 41/00 Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
• CPC Class Codes: C08L 5/02 Dextran; Derivatives thereof

Abstract

A tissue adhesive formed by reacting an aminodextran containing primary amine groups with an oxidized dextran containing aldehyde groups is described. The dextran-based polymer tissue adhesive is particularly useful in medical applications where low swell and slow degradation are needed, for example sealing the dura, ophthalmic procedures, tissue repair, antiadhesive applications, drug delivery, and as a plug to seal a fistula or the punctum.

Claims

1. A method for applying a coating to an anatomical site on tissue of a living organism comprising:

applying to the site

a) at least one dextran that has been derivatized to provide at least one aminodextran that contains primary amine groups, said at least one dextran having a weight-average molecular weight of about 1,000 to about 1,000,000 Daltons, said at least one aminodextran having an amine substitution level of about 5% to about 65%;

followed by

b) at least one dextran that has been oxidized to provide at least one oxidized dextran containing aldehyde groups, said at least one dextran having a weight-average molecular weight of about 1,000 to about 1,000,000 Daltons, said at least one oxidized dextran having an equivalent weight per aldehyde group of about 65 to about 1500 Daltons;

or applying (b) followed by (a) and mixing (a) and (b) on the site;

or premixing (a) and (b) and applying the resulting mixture to the site.

2. The method according to claim 1 wherein the aminodextran is a first aqueous solution or dispersion and the oxidized dextran a second aqueous solution or dispersion.

3. The method according to claim 2 wherein the first aqueous solution or dispersion contains the aminodextran at a concentration of about 5% to about 70% by weight relative to the total weight of the solution or dispersion.

4. The method according to claim 2 wherein the second aqueous solution or dispersion contains the oxidized dextran at a concentration of about 5% to about 50% by weight relative to the total weight of the solution or dispersion.

5. The method according to claim 1 wherein the aminodextran and the oxidized dextran are finely divided powders.

6. The method according to claim 1 wherein the equivalent weight per aldehyde group of the oxidized dextran is about 90 to about 1500 Daltons.

7. A method for bonding at least two anatomical sites together comprising:

applying to at least one of the at least two anatomical sites;

a) at least one dextran that has been derivatized to provide at least one aminodextran that contains primary amine groups, said at least one dextran having a weight-average molecular weight of about 1,000 to about 1,000,000 Daltons, said at least one aminodextran having an amine substitution level of about 5% to about 65%;

followed by

b) at least one dextran that has been oxidized to provide at least one oxidized dextran containing aldehyde groups, said at least one dextran having a weight-average molecular weight of about 1,000 to about 1,000,000 Daltons, said at least one oxidized dextran having an equivalent weight per aldehyde group of about 65 to about 1500 Daltons;

or alternatively, applying (b) followed by (a) and mixing (a) and (b) on the at least one site, or alternatively, premixing (a) and (b) and applying the resulting mixture to the at least one site; and

contacting the at least two anatomical sites together.

8. The method according to claim 7 wherein the aminodextran is a first aqueous solution or dispersion and the oxidized dextran a second aqueous solution or dispersion.

9. The method according to claim 8 wherein the first aqueous solution or dispersion contains the aminodextran at a concentration of about 5% to about 70% by weight relative to the total weight of the solution or dispersion.

10. The method according to claim 8 wherein the second aqueous solution or dispersion contains the oxidized dextran at a concentration of about 5% to about 50% by weight relative to the total weight of the solution or dispersion.

11. The method according to claim 7 wherein the aminodextran and the oxidized dextran are finely divided powders.

12. The method according to claim 7 wherein the equivalent weight per aldehyde group of the oxidized dextran is about 90 to about 1500 Daltons.